Eric Dean Gearhart, PA | |
10a Marshellen Dr, Beaufort, SC 29902-6900 | |
(843) 525-9015 | |
(843) 525-9020 |
Full Name | Eric Dean Gearhart |
---|---|
Gender | Male |
Speciality | Physician Assistant |
Experience | 21 Years |
Location | 10a Marshellen Dr, Beaufort, South Carolina |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063491025 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363AM0700X | Physician Assistant - Medical | 1053609 (* (Not Available)) | Secondary |
363AM0700X | Physician Assistant - Medical | 1634 (South Carolina) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Amedisys Home Health Of Beaufort | Ladys island, SC | Home health agency |
Beaufort County Memorial Hospital | Beaufort, SC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Beaufort County Memorial Hospital | 7810809365 | 103 |
News Archive
Celgene International Sàrl, a subsidiary of Celgene Corporation, announced results from a multi-center Phase I study that explored multiple dosing schedules of oral azacitidine in 23 patients with acute myeloid leukemia (AML), myelodysplastic syndromes or chronic myelomonocytic leukemia (CMML) who were not candidates for other therapies or who had failed previous regimens.
Using a novel aptamer-based proteomics array technology, researchers and collaborators have identified biomarkers and protein signatures that are hallmarks of cancer at an early stage for two of the most aggressive and deadly forms of cancer, pancreatic and mesothelioma.
Santarus, Inc., a specialty biopharmaceutical company, today announced that analysis of top-line safety data from a double blind, multicenter 12-month extended use study in patients treated daily with either the investigational drug budesonide MMX 6 mg or placebo will be provided as support for the company's planned submission of a New Drug Application (NDA) for budesonide MMX 9 mg to the U.S. Food and Drug Administration (FDA) for the induction of remission of mild or moderate active ulcerative colitis.
There is no question that the pandemic has been immensely stressful for health care workers, especially for those on the frontline of patient care. Yet, even before the pandemic, the regular demands of many health care industry jobs put these workers at risk for burnout.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Eric Dean Gearhart, PA Po Box 6216a, 1 Pinckney Blvd Naval Hospital Beaufort Attn Profession, Beaufort, SC 29902-6148 Ph: (843) 228-5577 | Eric Dean Gearhart, PA 10a Marshellen Dr, Beaufort, SC 29902-6900 Ph: (843) 525-9015 |
News Archive
Celgene International Sàrl, a subsidiary of Celgene Corporation, announced results from a multi-center Phase I study that explored multiple dosing schedules of oral azacitidine in 23 patients with acute myeloid leukemia (AML), myelodysplastic syndromes or chronic myelomonocytic leukemia (CMML) who were not candidates for other therapies or who had failed previous regimens.
Using a novel aptamer-based proteomics array technology, researchers and collaborators have identified biomarkers and protein signatures that are hallmarks of cancer at an early stage for two of the most aggressive and deadly forms of cancer, pancreatic and mesothelioma.
Santarus, Inc., a specialty biopharmaceutical company, today announced that analysis of top-line safety data from a double blind, multicenter 12-month extended use study in patients treated daily with either the investigational drug budesonide MMX 6 mg or placebo will be provided as support for the company's planned submission of a New Drug Application (NDA) for budesonide MMX 9 mg to the U.S. Food and Drug Administration (FDA) for the induction of remission of mild or moderate active ulcerative colitis.
There is no question that the pandemic has been immensely stressful for health care workers, especially for those on the frontline of patient care. Yet, even before the pandemic, the regular demands of many health care industry jobs put these workers at risk for burnout.
› Verified 7 days ago
Jessie C Santiago Jr., PA C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1 Pinckney Blvd, Attn Professional Affairs Coordinator, Beaufort, SC 29902 Phone: 843-228-5577 Fax: 843-228-5196 | |
Jenna Theresa Flint, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1 Pinckney Blvd, Beaufort, SC 29902 Phone: 843-228-5200 | |
Peyton Erb, Physician Assistant Medicare: Medicare Enrolled Practice Location: 989 Ribaut Rd Ste 210, Beaufort, SC 29902 Phone: 843-522-7820 | |
Denise Mcallister Mercier, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 989 Ribaut Rd Ste 340, Beaufort, SC 29902 Phone: 843-521-8484 Fax: 843-521-8485 | |
Theresa Ann Morris, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 27 Kemmerlin Ln, Primecare Health Center, Beaufort, SC 29907 Phone: 843-524-2100 | |
Kimberly Thorpe, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 300 Midtown Dr, Beaufort, SC 29906 Phone: 843-770-0404 |